Cellestia Biotech Employee Directory
Biotechnology ResearchBasel-stadt, Switzerland2-10 Employees
Cellestia Biotech is a Basel-based biotechnology research company focused on developing therapeutics with novel mechanisms of action to treat autoimmune diseases and multi-drug resistant cancers. Its clinical-stage drug candidate CB-103 has demonstrated safety and biological activity in humans and is advancing through Phase 2 investigator-initiated trials for resistant cancers, with a Proof-of-Concept study for graft-versus-host disease planned. The company emphasizes innovative approaches aimed at addressing difficult indications in the development of therapies. Based in Basel in the Basel-Stadt region of Switzerland, Cellestia operates in the biotechnology research sector with a small team. In April 2025, the company announced an integration with TVM Capital GmbH, signaling a notable strategic development in its corporate partnerships.